Treatment of Aeromonas hydrophila and Vibrio parahaemolyticus infections in Macrobrachium rosenbergii using bioactive compounds from marine Actinomycetes – an alternative to synthetic antibiotics

IF 3.5 3区 医学 Q3 IMMUNOLOGY
Haimanti Mondal, John Thomas
{"title":"Treatment of Aeromonas hydrophila and Vibrio parahaemolyticus infections in Macrobrachium rosenbergii using bioactive compounds from marine Actinomycetes – an alternative to synthetic antibiotics","authors":"Haimanti Mondal,&nbsp;John Thomas","doi":"10.1016/j.micpath.2025.108116","DOIUrl":null,"url":null,"abstract":"<div><div>Natural products from certain marine microorganisms have been used as an alternative to antibiotics in recent times for the treatment of infectious diseases in aquaculture. Marine <em>Actinomycetes</em> are the most prolific secondary metabolite producers. The aim of the present study was to extract the bioactive compounds from marine <em>Actinomycetes</em> extracts which can be used as a bioactive feed in treating the bacterial infection in prawns. This study investigated the antibacterial potential of <em>Actinomycetes</em> isolated from marine sediments against two aquatic pathogens, <em>Aeromonas hydrophila</em> and <em>Vibrio parahemolyticus</em>. A total of 17 distinctive colonies were screened and amongst them, 2 showed a broad-spectrum antibacterial activity. The strains were characterized based on cultural, morphological, and biochemical methods. 16S rRNA sequencing confirmed the isolates as <em>Microbacterium marinum</em> and <em>Kocuria rhizophila</em> falling under <em>Actinomycetes.</em> 7 purified compounds extracted from the two strains showed a good inhibition zone of 10–17 mm against <em>A. hydrophila</em> and 11–21 mm against <em>V. parahemolyticus</em> respectively. The survival rate of <em>Macrobrachium rosenbergii</em> after the bioactive feed treatment was found to be 80–90 %. The immunological, biochemical and antioxidant enzymatic activities showed increased activities and disease resistance. The gene expression analysis with immune genes by qRT-PCR revealed enhanced immune response. A difference in the data was regarded as statistically significant when the p significance value was less than or equal to 5 (<em>p</em> ≤ 0.05). The present study developed an alternative antimicrobial therapeutic treatment as an alternative to synthetic antibiotics against aquatic bacterial pathogens that can benefit the aquaculture farmers.</div></div>","PeriodicalId":18599,"journal":{"name":"Microbial pathogenesis","volume":"209 ","pages":"Article 108116"},"PeriodicalIF":3.5000,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial pathogenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0882401025008411","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Natural products from certain marine microorganisms have been used as an alternative to antibiotics in recent times for the treatment of infectious diseases in aquaculture. Marine Actinomycetes are the most prolific secondary metabolite producers. The aim of the present study was to extract the bioactive compounds from marine Actinomycetes extracts which can be used as a bioactive feed in treating the bacterial infection in prawns. This study investigated the antibacterial potential of Actinomycetes isolated from marine sediments against two aquatic pathogens, Aeromonas hydrophila and Vibrio parahemolyticus. A total of 17 distinctive colonies were screened and amongst them, 2 showed a broad-spectrum antibacterial activity. The strains were characterized based on cultural, morphological, and biochemical methods. 16S rRNA sequencing confirmed the isolates as Microbacterium marinum and Kocuria rhizophila falling under Actinomycetes. 7 purified compounds extracted from the two strains showed a good inhibition zone of 10–17 mm against A. hydrophila and 11–21 mm against V. parahemolyticus respectively. The survival rate of Macrobrachium rosenbergii after the bioactive feed treatment was found to be 80–90 %. The immunological, biochemical and antioxidant enzymatic activities showed increased activities and disease resistance. The gene expression analysis with immune genes by qRT-PCR revealed enhanced immune response. A difference in the data was regarded as statistically significant when the p significance value was less than or equal to 5 (p ≤ 0.05). The present study developed an alternative antimicrobial therapeutic treatment as an alternative to synthetic antibiotics against aquatic bacterial pathogens that can benefit the aquaculture farmers.
利用海洋放线菌的生物活性化合物治疗罗氏沼虾的嗜水气单胞菌和副溶血性弧菌感染——一种合成抗生素的替代品。
近年来,某些海洋微生物的天然产物已被用作抗生素的替代品,用于治疗水产养殖中的传染病。海洋放线菌是最多产的次生代谢物生产者。本研究旨在从海洋放线菌提取物中提取生物活性化合物,并将其作为生物活性饲料用于对虾细菌感染的治疗。研究了从海洋沉积物中分离的放线菌对两种水生病原菌——嗜水气单胞菌和副溶血性弧菌的抑菌潜力。共筛选出17个特色菌落,其中2个具有广谱抗菌活性。通过培养、形态学和生化方法对菌株进行了鉴定。通过16S rRNA测序,证实两株分离物分别为海洋微菌和嗜根Kocuria放线菌。两株分离物对嗜水单胞菌和副溶血性弧菌的抑制区分别为10 ~ 17 mm和11 ~ 21 mm。经生物活性饲料处理后,罗氏沼虾成活率达80 ~ 90%。免疫、生化和抗氧化酶活性增强,抗病能力增强。免疫基因qRT-PCR表达分析显示免疫应答增强。当p显著性值小于等于5 (p≤0.05)时,认为资料差异有统计学意义。本研究开发了一种替代合成抗生素治疗水生细菌病原体的替代抗菌治疗方法,可使水产养殖户受益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microbial pathogenesis
Microbial pathogenesis 医学-免疫学
CiteScore
7.40
自引率
2.60%
发文量
472
审稿时长
56 days
期刊介绍: Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports. Research Areas Include: -Pathogenesis -Virulence factors -Host susceptibility or resistance -Immune mechanisms -Identification, cloning and sequencing of relevant genes -Genetic studies -Viruses, prokaryotic organisms and protozoa -Microbiota -Systems biology related to infectious diseases -Targets for vaccine design (pre-clinical studies)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信